• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      Glenmark gets approval for marketing two products in US

      Posted AtThe Hindu Businessline

      MUMBAI: Pharmaceutical firm Glenmark on Friday said that it has received ANDA approval for its anti-inflammatory and anti-diabetic drugs and will soon commence marketing and distribution of these products in the US market.

      Glenmark Generics Ltd (GGL), a subsidiary of Glenmark Pharmaceuticals, has received the ANDA approval for Mometasone Furoate Ointment, Mometasone Furoate Cream and Metformin Hydrochloride tablets, the company said in a filing to the BSE.

      GGL now has a portfolio of 32 generic products for the US market and over 35 ANDAs awaiting USFDA approval process. The total sales for the two Mometasone Furoate products in the 12-month period ending March 31, 2008 were over $29 million, while, Metform in Hydrochloride used in the treatment of diabetics had a total sales of over $158 million for the year ended March 31, 2008 as per IMS Health.

      Mometasone would be manufactured at Glenmark's USFDA approved Baddi unit in Himachal Pradesh. GGL had earlier acquired the US manufacturing rights for a line of Chobetasol Propionate dermatology products through a US-based pharmaceutical development com pany. Shares of the company were trading at Rs 681, down 0.01 per cent on BSE in afternoon trade. - PTI


      May 30, 2008

       

      Share this Article!

    Back to top^